United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$799Mraised across 4 rounds since 2017, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
PfizerLead
Bessemer Venture Partners
Hatteras Venture Partners
Aju IB Investment
Sanofi Ventures
6 Dimensions Capital
MRL Ventures FundReported by FinSMEs and 1 other
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Redmile GroupLBessemer Venture Partners
Wellington Management
BlackRock
Janus Henderson InvestorsPfizerLBiotechnology Value FundLHatteras Venture PartnersAju IB InvestmentBain Capital Life SciencesMissing a round, or an investor who was in one? Tell us.
Kymera Therapeutics's investors include Redmile Group, Bessemer Venture Partners, Wellington Management, BlackRock and Janus Henderson Investors, and 13 more on record.
Kymera Therapeutics has raised $799M across 4 rounds since 2017.
Kymera Therapeutics's most recent round was an Undisclosed round of $602M in Dec 2025.
Its most recent round, $602M in Dec 2025, is also its largest on record.
Kymera Therapeutics's first round on record, in Oct 2017, was backed by Amgen and Atlas Venture/ Lilly.
Kymera Therapeutics's latest named round is an Undisclosed round, in Dec 2025.
Kymera Therapeutics is based in the United States.
Pfizer led the Series B in 2018; Redmile Group led the Series C in 2020.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
